In the Guidance, the FDA posits that poor pharmaceutical label design can contribute to medication errors. To reduce such errors, the FDA seemingly takes a "pro-trade dress" stance by warning ...

The judge said a 2022 law that prevented pharmacists from contacting patients about the efficacy of ivermectin and ...

A study recruited Black and Latina women and asked them to log all the beauty products they use in a week. Here's what the study found.

The draft guidance – which is open for comment until 7th April – proposes a risk-based assessment framework that drug developers ... such as user interface and labelling, data management ...

Increased 2025 guidance with expected net revenues of $768.0 million to $793.0 million, adjusted non-GAAP EBITDA of $195.0 ...

Q1 2025 Management View Liz Barrett, President and Chief Executive Officer, highlighted that "the new drug application for ...

Republicans and Democrats alike are questioning the deep staffing cuts, research funding freezes and drastic policy changes U ...

Mineralys Therapeutics reports strong Q1 2025 results, announcing pivotal trial success for lorundrostat, a $201M equity raise, and progress toward ...

Mounjaro. Ozempic. Wegovy. Zepbound. All these are brand names linked in some way to diabetes and weight loss-or, as the ...

A recent rise in search engine trends and consumer demand has pushed saffron into the spotlight alongside other popular ...

Dimerix and its kidney drug is on track but with results of its phase III trial not due for years, a few more twists and turns are likely.

Q1 2025 Earnings Call Transcript May 12, 2025 Xenon Pharmaceuticals Inc. beats earnings expectations. Reported EPS is $-0.83, ...